0439 : Incidence of inappropriate ICD shocks and other complications in asymptomatic versus symptomatic Brugada syndrome  by Bonny, Aimé et al.
© Elsevier Masson SAS. All rights reserved.
 
160 Archives of Cardiovascular Diseases Supplements (2015) 7, 160-161
Topic 16 – Electrophysiology, rythmology
and pacing – A
0439
Incidence of inappropriate ICD shocks and other complications in
asymptomatic versus symptomatic Brugada syndrome
Aimé Bonny (1), Marcus Ngantcha (2), Abdeslam Bouzeman (3), Jérôme
Taieb (4), Thibault Vaugrenard (4), Françoise Hidden-Lucet (5)
(1) CH Roubaix, Roubaix, France – (2) Biostatistic, Statprest, Paris,
France – (3) Institut Cardiovasculaire de Paris, Paris, France – (4) CH
Aix en Provence, Cardiologie, Aix En Provence, France – (5) APHP-GH
Pitié-Salpêtrière, Cardiologie, Rythmologie, Paris, France
Background: Brugada syndrome (BrS) requires implantation of cardio-
verter-defibrillator (ICD) to prevent sudden cardiac death. However, the ICD
indications in asymptomatic patients are remain conflicting.
Method and Results: We compared the rate of ICD complications in
asymptomatic versus symptomatic BrS patients. ICD interrogations were done
every 3-6 months. Given the low prevalence of BrS in the general population,
10% of the risk α for the bilateral statistical test significance was chosen. We
studied 51 patients, 86.5% male; mean age 47±11 years at diagnosis. At diag-
nosis, 18 patients (35%) were asymptomatic, 25 patients (49%) experienced
syncope, and 8 patients (16%) had been resuscitated from ventricular fibrilla-
tion. During a mean follow-up of 78±46 months, none of asymptomatic patients
experienced appropriate therapy, whereas 21.6% of symptomatic patients had
≥1 shocks. Overall complication rate was 27.4%. Inappropriate shocks (IS)
occurred in 7 patients (13.7%; mean 6.57±6.94 shocks per patient), 16.14±10.38
months after ICD implantation, and lead fracture was the first cause (n=4,
57.1%). The incidence of IS was higher in the asymptomatic patients (p=0.09).
Device-related complications were similar in both groups (p=1). A total of 14
patients (27.4%) had ≥1 complications. The mean interval from implantation to
a complication was 13.91±12.98 months. The most frequent complication was
lead failure in 9 (17.6%). The risk of IS and device-complications at 3 years was
13.7% and 21.6% respectively, and eventually remains constant over the time.
Conclusion: This study demonstrated that ICD has a high risk of compli-
cations, mainly during the early period after the device implantation. A higher
rate of IS as well as a very low risk of arrhythmic events in asymptomatic BrS
patients advocate to carefully evaluate this young and otherwise “healthy”
population for the decision-making.
0315
Atrioventricular conduction disturbance after transcatheter aortic
valve implantation: incidence and predictive factors
Laurence Jesel, Audrey Lefoulon, Halim Marzak, Nathan Messas, Michel
Chauvin, Olivier Morel, Patrick Ohlmann
Nouvel Hôpital Civil, Cardiologie- Rythmologie, Strasbourg, France
Purpose: Atrioventricular (AV) conduction disturbance leading to pace-
maker (PM) implantation is frequent after transcatheter aortic valve implanta-
tion (TAVI). The aim of this study was to assess the incidence and the
predictors of PM implantation after TAVI.
Methods: Between 2010 and 2014, 198 consecutive patients underwent
TAVI in our center. 42 patients were excluded from the study because of a
pre-existing PM before TAVI. 156 patients (62 Corevalve (CV), 94 Edwards
Sapiens valve (ES) were included and prospectively followed during 1 year.
Results: Complete AV block occurred after TAVI in 29 patients (19%),
second degree AV block in 3 (0.05%), new left bundle branch block (LBBB)
in 53 (34%). A PM was implanted in 40 patients (26%). CV patients were
more frequently implanted than ES (35% vs 19%; p=0.03). Post-procedure
PR, QRS duration were longer in the PM group (227 vs 196ms; 159 vs 129ms,
respectively, p<0.001). LBBB was also more frequent (79% vs 53%; p=0.01).
At hospital discharge, 83% of the PM group was stimulated. At 1 month, 10%
were PM dependent and 4% at 6 months. At 1 month, 29% were stimulated
less than 5% of the time and 25% at 6 months. Multivariate analysis showed
that the predictors of PM implantation were a pre-existing RBBB (OR 4.7, IC
1.43-15.52, p=0.01), a pre-existing LBBB (OR 7.28, IC 2.34-22.6, p<0.001),
a per-TAVI complete AV block (OR 4.21, IC 1.52-11.63, p=0.006), a high
prosthesis/annulus diameter ratio (OR 1.1, IC 1.04-1.18, p=0.003) and post-
procedure PR and QRS long duration (OR 1.03, IC 1.01-1.06, p=0.009; OR
1.04, IC 1.01-1.07, p=0.009 respectively). PM implantation had no impact on
survival after TAVI (Logrank=0.92). The increase in LVEF post-TAVI was
lower in PM group: 0.2 vs 8%, p=0.05 at 6 months and -5 vs 9.6%, p=0.004
at 1 year. The NYHA class was similar in both groups at follow up.
Conclusion: TAVI is associated in a great proportion of patients with AV
disturbances which are mostly regressive over time. Patients with pre-existing
RBBB, LBBB and high prosthesis/annulus diameter ratio are at increased risk
of complete AV block. LVEF increase was lower in PM group even with a
low percentage of stimulation time.
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Background: The rate of pacemaker (PM) implantations is continuously
growing. A large number of elderly patients is expected to be implanted in the
future. We aimed at analyzing the short and long-term outcome after PM
replacement in nonagenarians.
Methods: Patients aged ≥90 yo referred for PM replacement from January
2004 to July 2014 were retrospectively included. The primary clinical end-
point was total mortality.
Results: 62 patients were included (93.3±2.9yo at the time of PM replace-
ment). During the follow-up, 37 patients (59.7%) died. Survival rates were
84.2% (95%CI:71.8-91.5%), 66.9% (95%CI:51.8-78.2%) and 22.7%
(95%CI:10.6-37.7%) after 1, 2 and 5 years, respectively. Atrial fibrillation
(OR 2.44, 95%CI:1.07-5.58) and non-physiological pacing, (OR 2.52,
95%CI:1.12-5.65) were independent predictors of mortality.
Conclusion: PM replacement in nonagenarians is a safe and straightfor-
ward procedure. Patients living for a median time of 30 months after the
replacement.
Abstract 0344-Figure: Survival for nonagenarians after PM replacement
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